CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | KHAZI FAYAZ CEO of Elo Life Systems | Grant or award · Employee Stock Option (Right to Buy) | +41,240 | 41,240 | ||
| 2021-06-07 | KHAZI FAYAZ CEO of Elo Life Systems | Grant or award · Restricted Stock Units | +23,999 | 23,999 | ||
| 2021-06-07 | KANE MATTHEW R. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,312 | 1,312 | ||
| 2021-06-07 | KANE MATTHEW R. President and CEO | Grant or award · Restricted Stock Units | +763 | 763 | ||
| 2021-06-07 | Barton Shane VP & Corporate Controller | Grant or award · Employee Stock Option (Right to Buy) | +31,242 | 31,242 | ||
| 2021-06-07 | Barton Shane VP & Corporate Controller | Grant or award · Restricted Stock Units | +18,181 | 18,181 | ||
| 2021-06-07 | Scimeca Dario General Counsel and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +78,106 | 78,106 | ||
| 2021-06-07 | Scimeca Dario General Counsel and Secretary | Grant or award · Restricted Stock Units | +45,454 | 45,454 | ||
| 2021-06-07 | Scimeca Dario General Counsel and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +46,629 | 46,629 | ||
| 2021-06-07 | Scimeca Dario General Counsel and Secretary | Grant or award · Restricted Stock Units | +27,136 | 27,136 | ||
| 2021-06-07 | Kelly John Alexander Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,159 | 117,159 | ||
| 2021-06-07 | Kelly John Alexander Chief Financial Officer | Grant or award · Restricted Stock Units | +68,181 | 68,181 | ||
| 2021-06-07 | Kelly John Alexander Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +70,295 | 70,295 | ||
| 2021-06-07 | Kelly John Alexander Chief Financial Officer | Grant or award · Restricted Stock Units | +40,908 | 40,908 | ||
| 2021-06-07 | JANTZ DEREK Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +101,537 | 101,537 | ||
| 2021-06-07 | JANTZ DEREK Chief Scientific Officer | Grant or award · Restricted Stock Units | +59,090 | 59,090 | ||
| 2021-06-07 | JANTZ DEREK Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +62,875 | 62,875 | ||
| 2021-06-07 | JANTZ DEREK Chief Scientific Officer | Grant or award · Restricted Stock Units | +36,590 | 36,590 | ||
| 2021-05-17 | JANTZ DEREK Chief Scientific Officer | Sale | −20,000 | $9.38 | $188K | 4,032,279 |
| 2021-05-14 | JANTZ DEREK Chief Scientific Officer | Option exercise | +21,514 | $0.04 | $861 | 4,061,952 |
Page 19 of 23 · 456 trades